Attenuated measles virus as a vaccine vector. - Wikidata - wikimedia - TriplyDB

Attenuated measles virus as a vaccine vector.

Attenuated measles virus as a vaccine vector.

http://www.wikidata.org/entity/Q36999524

about

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys.Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.An immune competent mouse model for the characterization of recombinant measles vaccines.Tunable and reversible drug control of protein production via a self-excising degron.Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates.Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.Replicating and non-replicating viral vectors for vaccine development The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.Measles vaccination: new strategies and formulations.Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens.Applications and challenges of multivalent recombinant vaccines.RNA-based viral vectors.Vaccine platform recombinant measles virus.Multivalent and Multipathogen Viral Vector Vaccines.Novel viral vectors in infectious diseases.Development of Recombinant Measles Virus-Based Vaccines.Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350.Measles virus.Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector.Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development New Vaccine Technologies to Combat Outbreak Situations

P2860

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

P2860

Attenuated measles virus as a vaccine vector.

http://www.wikidata.org/entity/Q36999524

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Attenuated measles virus as a vaccine vector.

@en

type

label

Attenuated measles virus as a vaccine vector.

@en

prefLabel

Attenuated measles virus as a vaccine vector.

@en

P1433

Q36999524-E5D9D40D-08C4-47E5-AF58-2549C8CCCEDE

P1476

Q36999524-0594FA5E-8169-427A-925E-8A5BD440DE98

P2093

Q36999524-080F7C57-887D-4F9F-BBE6-31EE07AFCA86

Q36999524-1121153F-13C7-45E2-B113-7549F6B300C1

Q36999524-133B67F4-11C0-45FB-971E-AEA92175A793

Q36999524-1559206E-B936-4B3E-8690-4E3A9DE1EB41

Q36999524-36D9FCDE-A0BF-4E50-8B81-62A7867905D4

Q36999524-439F82A8-C54C-49DC-B2BE-50622EBE2D02

Q36999524-4D0259B8-F93A-4D91-9CA3-15FC435736E4

Q36999524-4F3E1B54-9307-4C35-85BA-25B947BD379C

Q36999524-816A826E-64F2-4415-89F9-3623D382857B

Q36999524-CA7300CD-1245-49F2-B68E-22D80BAD6032

P2860

Q36999524-0BA594A5-1E1E-41B9-A574-6E5A88196343

Q36999524-0E804A57-EAEF-4874-80B3-B74B2D8C5D65

Q36999524-1B167CDB-6AC5-44AA-83DA-787DB05325E8

Q36999524-2D6A92CE-B5D6-40C8-BA71-A0E1BE19EA98

Q36999524-3845A324-1650-4843-8717-4318C06C1BEE

Q36999524-45AD27CC-6A36-4B6B-A128-91BD86D61C63

Q36999524-4653735D-92EA-45BB-894B-614414CD9355

Q36999524-6BA3823F-9F83-4DE9-A2BC-48858EC880B7

Q36999524-80AFA215-9278-414D-B7DB-3879EC6B11C0

Q36999524-9AF1670F-9B6E-477B-B6B0-2ABFD2666CF0

P304

Q36999524-0F27ABDC-71B8-4682-8170-95B9805F99AC

P31

Q36999524-77E26BA6-09DC-49B2-9904-F0BF9696DC96

P356

Q36999524-F8EE9866-3D6E-46B8-B3F1-E23139CF8DCC

P407

Q36999524-01876F23-B352-4C94-A492-913BDC918A0B

P433

Q36999524-EAE54E23-E148-442E-8C60-DE305C792567

P478

Q36999524-39F4AF3A-EDAB-4680-AE87-14A326D8C1B9

P577

Q36999524-1C19B20D-6E61-4B88-BDA5-978861D8DA03

P5875

Q36999524-AFAD8361-C1F6-4BBF-89D8-0F26182E57BB

P698

Q36999524-819C62FF-8C3C-4896-BBCB-F7B28743EE2A

P921

Q36999524-41292C4F-F265-4D40-92EF-E18896252772

Q36999524-97F50B01-FC47-4B12-BB29-3F6B29DE74DC

Q36999524-ED8528FA-4DE8-4E10-9D5A-B5478279A2F6

P932

Q36999524-D9A94AF8-B8F1-44BE-BF55-39578880B8B2

P356

J.VACCINE.2007.01.064

P1433

P1476

Attenuated measles virus as a vaccine vector.

@en

P2093

Armando Zuniga

http://www.w3.org/2001/XMLSchema#string

Hussein Y Naim

http://www.w3.org/2001/XMLSchema#string

Jean Francois Viret

http://www.w3.org/2001/XMLSchema#string

Jovan Pavlovic

http://www.w3.org/2001/XMLSchema#string

Lars Hangartner

http://www.w3.org/2001/XMLSchema#string

Martin A Billeter

http://www.w3.org/2001/XMLSchema#string

Matthias Liniger

http://www.w3.org/2001/XMLSchema#string

Michael Caballero

http://www.w3.org/2001/XMLSchema#string

Peter Wild

http://www.w3.org/2001/XMLSchema#string

Reinhard Glueck

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric measles viruses with a foreign envelope

The danger model: a renewed sense of self

Measles virus spread and pathogenesis in genetically modified mice.

Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.

Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion

Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications.

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Virus-like particle and DNA-based candidate AIDS vaccines.

P304

2974-2983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2007.01.064

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6502763

http://www.w3.org/2001/XMLSchema#string

P698

17303293

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

vector-borne disease

P932

3707277

http://www.w3.org/2001/XMLSchema#string